Simplex Trading
IRD

Simplex Trading’s Opus Genetics IRD Stock Holding History

Simplex Trading’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$375K Buy
82,480
+73,417
+810% +$254K ﹤0.01% 3590
2025
Q4 		$18.2K Sell
9,063
-23,784
-72% -$48.3K ﹤0.01% 6564
2025
Q3 		$54K Buy
+32,847
New +$40.8K ﹤0.01% 6384
2025
Q2 		– Sell
-1,618
Closed -$1.5K – 9963
2025
Q1 		$1K Buy
+1,618
New +$1.81K ﹤0.01% 8352
2024
Q3 		– Sell
-1,335
Closed -$2.06K – 9797
2024
Q2 		$2K Sell
1,335
-799
-37% -$1.38K ﹤0.01% 8382
2024
Q1 		$4K Sell
2,134
-7,895
-79% -$20K ﹤0.01% 8182
2023
Q4 		$30K Buy
10,029
+2,424
+32% +$7.17K ﹤0.01% 6568
2023
Q3 		$25K Buy
+7,605
New +$30.5K ﹤0.01% 6445
2023
Q2 		– Sell
-13,776
Closed -$65.4K – 10144
2023
Q1 		$51K Buy
13,776
+2,140
+18% +$7.68K ﹤0.01% 5911
2022
Q4 		$41K Buy
+11,636
New +$30.6K ﹤0.01% 6126
2022
Q2 		– Sell
-10,243
Closed -$23.3K – 11325
2022
Q1 		$33K Buy
+10,243
New +$35.1K ﹤0.01% 7679

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Simplex Trading's IRD Position: Q1 2026 in Review

Simplex Trading increased its Opus Genetics (IRD) stake by 810% in Q1 2026, buying an estimated $254K and bringing the position to 82,480 shares worth $375K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.

Simplex Trading first reported a position in IRD in Q1 2022 and has held it in 11 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Simplex Trading held 82,480 shares of Opus Genetics worth $375K as of Q1 2026.
  • Simplex Trading bought 73,417 Opus Genetics shares in Q1 2026, an estimated $254K.
  • Opus Genetics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3590 holding.
  • Simplex Trading first reported a position in Opus Genetics in Q1 2022 and has held it in 11 quarters since.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.